{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:03:55Z","timestamp":1792515835275,"version":"4.5.0"},"reference-count":296,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3601800"],"award-info":[{"award-number":["2022YFC3601800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430102"],"award-info":[{"award-number":["82430102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141004"],"award-info":[{"award-number":["32141004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203933"],"award-info":[{"award-number":["82203933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373489"],"award-info":[{"award-number":["82373489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330098"],"award-info":[{"award-number":["82330098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MedComm"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Systemic lupus erythematosus (SLE) is a multifaceted dautoimmune disease driven by complex interactions among genetic, environmental, and sex\u2010related factors. Central to its pathogenesis are type I interferons (IFN\u2010I) and autoantibodies that target nucleic acids and nucleic acid\u2010binding proteins. These mediators, often triggered by environmental stimuli in genetically susceptible individuals, promote sustained immune activation and chronic inflammation. Despite advances in understanding the immunological landscape of SLE, the precise initiating triggers and early molecular events remain incompletely defined. Recent studies have highlighted the destabilization of innate immune cells, particularly dendritic cells and monocytes, as critical early events in the pathogenesis of SLE. These alterations precede and potentially initiate the downstream activation of autoreactive lymphocytes. This review provides an updated synthesis of key epidemiological findings, emerging pathogenic mechanisms, potential therapeutic targets, and advances in translational and clinical research. Particular attention is given to recent insights into disease triggers and early pathological processes, especially the destabilization of innate immune cells. By consolidating these advances, this review aims to refine our understanding of the early immune dysregulation in SLE and to support the development of more precise, mechanism\u2010based therapeutic strategies.<\/jats:p>","DOI":"10.1002\/mco2.70246","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:57:49Z","timestamp":1749725869000},"source":"Crossref","is-referenced-by-count":12,"title":["New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus"],"prefix":"10.1002","volume":"6","author":[{"given":"Jingru","family":"Tian","sequence":"first","affiliation":[{"name":"Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"},{"name":"Key Laboratory of Basic and Translational Research on Immune\u2010Mediated Skin Diseases Chinese Academy of Medical Sciences  Nanjing China"},{"name":"Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs  Nanjing China"},{"name":"Department of Allergy and Rheumatology Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"},{"name":"Key Laboratory of Basic and Translational Research on Immune\u2010Mediated Skin Diseases Chinese Academy of Medical Sciences  Nanjing China"},{"name":"Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology Huashan Hospital Fudan University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yao","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"},{"name":"Department of Allergy and Rheumatology Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[{"name":"Hospital for Skin Diseases Institute of Dermatology Chinese Academy of Medical Sciences and Peking Union Medical College  Nanjing China"},{"name":"Key Laboratory of Basic and Translational Research on Immune\u2010Mediated Skin Diseases Chinese Academy of Medical Sciences  Nanjing China"},{"name":"Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.10.007"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00668-1"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05183-4"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.02.004"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40191"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40192"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000614"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41632"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206334"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38238"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20683"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead297"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223741"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118025"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113123"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.176"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2011.49"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.277"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350310"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3528"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20999"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222345"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39504"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.81"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2014.23"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12089"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21049-y"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118552"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51864-9"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16021"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1341272"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.12.037"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210952"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626217"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01548-14"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746998"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1031079"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02422-9"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.11.009"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S305225"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7201"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2306"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41511"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42016"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102777"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.032"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13603-6"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.02.012"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2220"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42008"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2081474"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.02.023"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3646"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600110069013"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05379.x"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2622"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800650"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107633"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.021"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2006.02367.x"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00524-z"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106065"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0386-1"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101921-042422"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19918-z"},{"issue":"10","key":"e_1_2_12_71_1","first-page":"575","article-title":"Emerging Concepts of Type I Interferons in SLE Pathogenesis and Therapy","volume":"18","author":"Psarras A.","year":"2022","journal-title":"Nature Reviews Rheumatology"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019097118"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93009"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.10.005"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001201"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.235122"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213181"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07820-3"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01681-z"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36522-z"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01084-z"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2194"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4575"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215820"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211287"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3782"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00993-3"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm9811"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137866"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20254"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050914"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40396"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153619"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132620"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160614158"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09102"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.009"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1064890"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73654-4"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00430"},{"key":"e_1_2_12_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.05.012"},{"key":"e_1_2_12_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224788"},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01240-z"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-022-01554-6"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn6537"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.12.017"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35209-1"},{"key":"e_1_2_12_109_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/385297"},{"key":"e_1_2_12_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3143"},{"key":"e_1_2_12_111_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi9769"},{"key":"e_1_2_12_112_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225433"},{"key":"e_1_2_12_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.09.004"},{"key":"e_1_2_12_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214379"},{"key":"e_1_2_12_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x"},{"key":"e_1_2_12_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.610"},{"key":"e_1_2_12_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.03.030"},{"key":"e_1_2_12_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.07.021"},{"key":"e_1_2_12_119_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30313"},{"key":"e_1_2_12_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02887.x"},{"key":"e_1_2_12_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2176-8"},{"key":"e_1_2_12_122_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900532"},{"key":"e_1_2_12_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa263"},{"key":"e_1_2_12_124_1","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2020-0212"},{"key":"e_1_2_12_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.10.003"},{"key":"e_1_2_12_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47691-w"},{"key":"e_1_2_12_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-019-08773-6"},{"key":"e_1_2_12_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.03.008"},{"issue":"4","key":"e_1_2_12_129_1","first-page":"676","article-title":"Innate Lymphoid Cells Are Increased in Systemic Lupus Erythematosus","volume":"37","author":"Hou M.","year":"2019","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_12_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07907-x"},{"key":"e_1_2_12_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez564"},{"key":"e_1_2_12_132_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1205405"},{"key":"e_1_2_12_133_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212794"},{"key":"e_1_2_12_134_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081892"},{"key":"e_1_2_12_135_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402782"},{"key":"e_1_2_12_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2016.09.001"},{"key":"e_1_2_12_137_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00874-1"},{"key":"e_1_2_12_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1771-0"},{"key":"e_1_2_12_139_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9657"},{"key":"e_1_2_12_140_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi4994"},{"key":"e_1_2_12_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25032"},{"key":"e_1_2_12_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00660-5"},{"key":"e_1_2_12_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.04.023"},{"key":"e_1_2_12_144_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221985"},{"key":"e_1_2_12_145_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130062"},{"key":"e_1_2_12_146_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac032"},{"key":"e_1_2_12_147_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.156341"},{"key":"e_1_2_12_148_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217646"},{"key":"e_1_2_12_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07627-2"},{"key":"e_1_2_12_150_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520112113"},{"key":"e_1_2_12_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00398-2"},{"key":"e_1_2_12_152_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000815"},{"key":"e_1_2_12_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.12.014"},{"key":"e_1_2_12_154_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4271"},{"key":"e_1_2_12_155_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22312-y"},{"key":"e_1_2_12_156_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300123"},{"key":"e_1_2_12_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.041"},{"key":"e_1_2_12_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0677-6"},{"key":"e_1_2_12_159_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223506"},{"key":"e_1_2_12_160_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-092419-031130"},{"key":"e_1_2_12_161_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0056-8"},{"key":"e_1_2_12_162_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf8531"},{"key":"e_1_2_12_163_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41641"},{"key":"e_1_2_12_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.08.015"},{"key":"e_1_2_12_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04642-z"},{"key":"e_1_2_12_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3326"},{"key":"e_1_2_12_167_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01049-2"},{"key":"e_1_2_12_168_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171976"},{"key":"e_1_2_12_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.06.016"},{"key":"e_1_2_12_170_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.2.279"},{"key":"e_1_2_12_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.046"},{"key":"e_1_2_12_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.09.031"},{"key":"e_1_2_12_173_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230774"},{"key":"e_1_2_12_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54941-4"},{"key":"e_1_2_12_175_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01798-w"},{"key":"e_1_2_12_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.06.024"},{"key":"e_1_2_12_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100075"},{"key":"e_1_2_12_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42652"},{"key":"e_1_2_12_179_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41608"},{"key":"e_1_2_12_180_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220920"},{"key":"e_1_2_12_181_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42462"},{"key":"e_1_2_12_182_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70055"},{"key":"e_1_2_12_183_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41811"},{"key":"e_1_2_12_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_2_12_185_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"e_1_2_12_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103692"},{"key":"e_1_2_12_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02265-7"},{"key":"e_1_2_12_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113433"},{"key":"e_1_2_12_189_1","unstructured":"Biogen \u201cA Study to Learn About the Safety of litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (TOPAZ\u20102) \u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04961567."},{"key":"e_1_2_12_190_1","unstructured":"Biogen \u201cA Study to Learn About the Safety of litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04895241."},{"key":"e_1_2_12_191_1","unstructured":"Biogen \u201cAn Extension Study to Learn More About the Long\u2010term Safety of litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (EMERALD)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05352919."},{"key":"e_1_2_12_192_1","unstructured":"Eisai Co. Ltd. \u201cA Study to Assess the Safety Tolerability and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05278663."},{"key":"e_1_2_12_193_1","unstructured":"Zenas BioPharma (USA) LLC \u201cA Study of obexelimab in Patients With Systemic Lupus Erythematosus (SunStone)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06559163."},{"key":"e_1_2_12_194_1","unstructured":"Hoffmann\u2010La Roche \u201cA Study to Evaluate the Efficacy and Safety of obinutuzumab in Patients With ISN\/RPS 2003 Class III or IV Lupus Nephritis (REGENCY)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04221477."},{"key":"e_1_2_12_195_1","unstructured":"Peking Union Medical College Hospital \u201cEfficacy and Safety of Telitacicept in Early SLE\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05899907."},{"key":"e_1_2_12_196_1","unstructured":"F.Li \u201cMulti\u2010omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05666336."},{"key":"e_1_2_12_197_1","unstructured":"S.Li \u201cA Clinical Study on the Effect of Telitacicept on Lymphocyte Subsets in the Treatment of Moderate to Severe Active Systemic Lupus Erythematosus\u201d Chictr.org.cn accessed May 6 2025 https:\/\/www.chictr.org.cn\/showproj.html?proj=207784."},{"key":"e_1_2_12_198_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06874-w"},{"key":"e_1_2_12_199_1","unstructured":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School \u201cThe Study of Comparing the Efficacy and Safety of human Umbilical Cord MSCs and Low\u2010dose IL\u20102 in the Treatment of LN\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05631717."},{"key":"e_1_2_12_200_1","unstructured":"L.Tian \u201cEfficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05339217."},{"key":"e_1_2_12_201_1","unstructured":"Peking University People's Hospital \u201cEfficacy and Immunological Evaluation of belimumab plus Low Dose IL\u20102 in the Treatment of Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05262686."},{"key":"e_1_2_12_202_1","unstructured":"Cugene Inc. \u201cA Phase Ia Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05328557."},{"key":"e_1_2_12_203_1","unstructured":"UCB Biopharma SRL \u201cA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04976322."},{"key":"e_1_2_12_204_1","unstructured":"Assiut University \u201cEfficiency of Use of baracetinib in Treatment of Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05432531."},{"key":"e_1_2_12_205_1","unstructured":"Bristol\u2010Myers Squibb \u201cA Study to Evaluate Effectiveness and Safety of deucravacitinib (BMS\u2010986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05620407."},{"key":"e_1_2_12_206_1","unstructured":"AstraZeneca \u201cAn Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants (BLOSSOM)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05835310."},{"key":"e_1_2_12_207_1","unstructured":"AstraZeneca \u201cPhase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis(IRIS)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05138133."},{"key":"e_1_2_12_208_1","unstructured":"Q.Lu \u201cFecal Microbiota Transplantation in the Treatment of Active Systemic Lupus Erythematosus: A Randomized Double\u2010blind Placebo\u2010controlled National Multi\u2010center Clinical Trial \u201d chictr.org.cn accessed May 6 2025 https:\/\/www.chictr.org.cn\/showproj.html?proj=136062."},{"key":"e_1_2_12_209_1","unstructured":"Shanghai Ming Ju Biotechnology Co. Ltd. \u201cCD19\u2010CART(relma\u2010cel) for Moderate to Severe Active Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05765006."},{"key":"e_1_2_12_210_1","unstructured":"Miltenyi Biomedicine GmbH \u201cMB\u2010CART19.1 in Refractory SLE\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06189157."},{"key":"e_1_2_12_211_1","unstructured":"Columbia University \u201cA Study of NKX019 a CD19 CAR NK Cell Therapy in Subjects With Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06518668."},{"key":"e_1_2_12_212_1","unstructured":"Second Affiliated Hospital School of Medicine Zhejiang University \u201cAnti\u2010CD19 CAR\u2010NK Cells in Refractory\/Relapsed Systemic Lupus Erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06421701."},{"key":"e_1_2_12_213_1","unstructured":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School \u201cIMPT\u2010514 in Systemic Lupus Erythematosus Anca\u2010associated Vasculitis and Idiopathic Inflammatory Myopathy\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06462144."},{"key":"e_1_2_12_214_1","unstructured":"RenJi Hospital \u201cJWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases \u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06567080."},{"key":"e_1_2_12_215_1","unstructured":"Essen Biotech \u201cSequential CAR\u2010T Cells Targeting BCMA\/CD19 in Patients With Relapsed\/Refractory Autoimmune Diseases\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06428188."},{"key":"e_1_2_12_216_1","unstructured":"Essen Biotech \u201cFourth\u2010gen CAR T Cells Targeting BCMA\/CD19 for Refractory Systemic Lupus Eythematosus (SLE)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06350110."},{"key":"e_1_2_12_217_1","unstructured":"Guangdong Ruishun Biotech Co. Ltd \u201cA Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06340490."},{"key":"e_1_2_12_218_1","unstructured":"Novartis Pharmaceuticals \u201cStudy of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III\u2010IV \u00b1 V\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05268289."},{"key":"e_1_2_12_219_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175962"},{"key":"e_1_2_12_220_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1176"},{"key":"e_1_2_12_221_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.28841"},{"key":"e_1_2_12_222_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003412"},{"key":"e_1_2_12_223_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2145281"},{"key":"e_1_2_12_224_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206939"},{"key":"e_1_2_12_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27233"},{"key":"e_1_2_12_226_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34359"},{"key":"e_1_2_12_227_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.17096"},{"key":"e_1_2_12_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.10.009"},{"key":"e_1_2_12_229_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"e_1_2_12_230_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01210-9"},{"key":"e_1_2_12_231_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000442"},{"key":"e_1_2_12_232_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0024"},{"key":"e_1_2_12_233_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00398-7"},{"key":"e_1_2_12_234_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39594"},{"key":"e_1_2_12_235_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15232"},{"key":"e_1_2_12_236_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614598"},{"key":"e_1_2_12_237_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000919"},{"key":"e_1_2_12_238_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac150"},{"key":"e_1_2_12_239_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202645"},{"key":"e_1_2_12_240_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917246"},{"key":"e_1_2_12_241_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221078825"},{"key":"e_1_2_12_242_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.362"},{"key":"e_1_2_12_243_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfw022"},{"key":"e_1_2_12_244_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key042"},{"key":"e_1_2_12_245_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-018-0278-1"},{"key":"e_1_2_12_246_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42620"},{"key":"e_1_2_12_247_1","unstructured":"EMD Serono \u201cAtacicept Phase 2\/3 in Generalized Systemic Lupus Erythematosus (APRIL\u2010SLE)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT00624338."},{"key":"e_1_2_12_248_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab115"},{"key":"e_1_2_12_249_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224854"},{"key":"e_1_2_12_250_1","unstructured":"Alpine Immune Sciences Inc. \u201cA Study of ALPN\u2010303 in Adult Healthy Volunteers (RUBY\u20101)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05034484."},{"key":"e_1_2_12_251_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.18"},{"key":"e_1_2_12_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.03.003"},{"key":"e_1_2_12_253_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-2078"},{"key":"e_1_2_12_254_1","unstructured":"Bristol\u2010Myers Squibb \u201cEfficacy and Safety Study of abatacept to Treat Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT00430677."},{"key":"e_1_2_12_255_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30018-9"},{"key":"e_1_2_12_256_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396"},{"key":"e_1_2_12_257_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4148"},{"key":"e_1_2_12_258_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1293"},{"key":"e_1_2_12_259_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229"},{"key":"e_1_2_12_260_1","unstructured":"Peking University People's Hospital \u201cLow\u2010dose IL\u20102 (interleukin\u20102) Treatment in SLE\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT02084238."},{"key":"e_1_2_12_261_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222501"},{"key":"e_1_2_12_262_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01350-6"},{"key":"e_1_2_12_263_1","unstructured":"Amgen \u201cSafety Tolerability Pharmacokinetics Pharmacodynamics and Immunogenicity of Efavaleukin alfa in Participants With Systemic lupus erythematosus\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT03451422."},{"key":"e_1_2_12_264_1","unstructured":"Nektar Therapeutics \u201cA Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04433585."},{"key":"e_1_2_12_265_1","unstructured":"Novartis Pharmaceuticals \u201cStudy the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT03656562."},{"key":"e_1_2_12_266_1","unstructured":"Boehringer Ingelheim \u201cAn Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT03385564."},{"key":"e_1_2_12_267_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42557"},{"key":"e_1_2_12_268_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40479"},{"key":"e_1_2_12_269_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31363-1"},{"key":"e_1_2_12_270_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02607-1"},{"key":"e_1_2_12_271_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02546-6"},{"key":"e_1_2_12_272_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42391"},{"key":"e_1_2_12_273_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221478"},{"key":"e_1_2_12_274_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00184-7"},{"key":"e_1_2_12_275_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00761-z"},{"key":"e_1_2_12_276_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1593141"},{"issue":"3","key":"e_1_2_12_277_1","first-page":"265","article-title":"Secukinumab\u2010induced Systemic Lupus Erythematosus in Psoriatic Arthritis","volume":"2","author":"\u00c1vila\u2010Ribeiro P.","year":"2023","journal-title":"ARP Rheumatology"},{"key":"e_1_2_12_278_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001511"},{"key":"e_1_2_12_279_1","unstructured":"Novartis Pharmaceuticals \u201cOpen\u2010label Extension Study of Efficacy Safety and Tolerability of secukinumab in Patients With Active Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT05232864."},{"key":"e_1_2_12_280_1","unstructured":"Suzhou Suncadia Biopharmaceuticals Co. Ltd. \u201cA Phase II Study to Evaluate the Efficacy and Safety of SHR\u20101314 in Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04924296."},{"key":"e_1_2_12_281_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90111"},{"key":"e_1_2_12_282_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-023-01115-8"},{"key":"e_1_2_12_283_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214856"},{"key":"e_1_2_12_284_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102867"},{"key":"e_1_2_12_285_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102844"},{"key":"e_1_2_12_286_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-019-0102-5"},{"key":"e_1_2_12_287_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03432-2"},{"key":"e_1_2_12_288_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27548"},{"key":"e_1_2_12_289_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211073"},{"key":"e_1_2_12_290_1","unstructured":"Chinese PLA General Hospital \u201cMesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06485648."},{"key":"e_1_2_12_291_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211790"},{"key":"e_1_2_12_292_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02092-5"},{"key":"e_1_2_12_293_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0472-1"},{"key":"e_1_2_12_294_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav1648"},{"key":"e_1_2_12_295_1","unstructured":"Shanghai Changzheng Hospital \u201cAnti\u2010CD19\u2010CD3E\u2010CAR\u2010T Cells in Relapsed\/\u200bRefractory Autoimmune Disease\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT06373081."},{"key":"e_1_2_12_296_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.027"},{"key":"e_1_2_12_297_1","unstructured":"Novartis Pharmaceuticals \u201cStudy of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE\u2010IgAN)\u201d ClinicalTrials.gov accessed May 6 2025 https:\/\/clinicaltrials.gov\/study\/NCT04578834."}],"container-title":["MedComm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mco2.70246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:25:16Z","timestamp":1754904316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mco2.70246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":296,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/mco2.70246"],"URL":"https:\/\/doi.org\/10.1002\/mco2.70246","archive":["Portico"],"relation":{},"ISSN":["2688-2663","2688-2663"],"issn-type":[{"value":"2688-2663","type":"print"},{"value":"2688-2663","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"e70246"}}